Onchocerciasis
Molting Larval Antigens Potential Targets for Vaccine
Published in Vaccine Weekly, February 16th, 2000
"Within the framework of ongoing studies on the identification of Onchocerca volvulus molting larval antigens as potential targets for vaccine development, we used a well-defined serum pool from putatively immune (PI) individuals to immunoscreen an O. volvulus third-stage larval (L3) cDNA expression library (SAW94WL-OvL3)," wrote W. Tawe and colleagues from the Lindsley F. Kimball Research Institute, New York. "We present the characterization of one of the isolated clones, the Ov-VAA-1."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2000-02-16)
More Articles from Vaccine Weekly
- Polio
Scientists Fear Vaccine Virus Could Persist After Eradication Is Achieved - Malaria Vaccines
Sequence Diversity of Plasmodium falciparum Evaluated - Rabies Vaccination
Immunogenicity of Rabies Postexposure Booster Injections Evaluated - Tuberculosis
ESAT-6 Vaccine Evaluated Against TB - Vaccine Delivery
Dual Administration of HAV and Yellow Fever Vaccines Evaluated - Varicella Vaccination
Costs and Benefits of Varicella Screening/Vaccination Evaluated - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
